Mwanzo207940 • KRX
add
Samsung Biologics Co Ltd
Bei iliyotangulia
₩ 1,116,000.00
Bei za siku
₩ 1,110,000.00 - ₩ 1,145,000.00
Bei za mwaka
₩ 721,000.00 - ₩ 1,209,000.00
Thamani ya kampuni katika soko
79.71T KRW
Wastani wa hisa zilizouzwa
elfu 76.58
Uwiano wa bei na mapato
73.58
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.26T | 17.04% |
Matumizi ya uendeshaji wa biashara | 334.17B | 87.16% |
Mapato halisi | 321.49B | 10.60% |
Kiwango cha faida halisi | 25.59 | -5.50% |
Mapato kwa kila hisa | elfu 4.52 | 10.60% |
EBITDA | 476.48B | -3.14% |
Asilimia ya kodi ya mapato | 14.04% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.33T | -35.26% |
Jumla ya mali | 17.34T | 8.04% |
Jumla ya dhima | 6.43T | 3.47% |
Jumla ya hisa | 10.90T | — |
hisa zilizosalia | 71.17M | — |
Uwiano wa bei na thamani | 7.28 | — |
Faida inayotokana na mali | 4.88% | — |
Faida inayotokana mtaji | 6.80% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 321.49B | 10.60% |
Pesa kutokana na shughuli | 389.56B | -53.23% |
Pesa kutokana na uwekezaji | -1.07T | -138.92% |
Pesa kutokana na ufadhili | 514.35B | 280.15% |
Mabadiliko halisi ya pesa taslimu | -149.00B | -267.89% |
Mtiririko huru wa pesa | -30.00B | -107.16% |
Kuhusu
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2011
Tovuti
Wafanyakazi
4,744
